Breast cancer staging and diagnostic testing help healthcare professionals determine whether cancer is present, understand its characteristics, and evaluate how far it has progressed. The diagnostic process may include clinical examinations, mammograms, ultrasound scans, biopsies, and additional imaging when necessary. After diagnosis, doctors assess tumor size, lymph node involvement, and whether cancer has spread to other parts of the body.
Breast cancer staging describes the extent of cancer in the body at the time of diagnosis. Diagnostic testing provides the information needed to confirm the disease and identify its characteristics. Doctors consider several factors, including the size of the tumor, involvement of nearby lymph nodes, and evidence of distant spread. They may also evaluate hormone receptor status and HER2 status because these biological features influence treatment decisions. The combination of examination findings, laboratory results, imaging, and tissue analysis helps healthcare professionals develop an appropriate care plan for each patient.
Breast cancer is commonly classified using the TNM staging system, which evaluates the primary tumor, nearby lymph nodes, and distant metastasis. Doctors combine these findings with other clinical and biological information to determine the overall stage. Staging may be described as clinical staging before treatment or pathological staging when surgical tissue results are available.
The main stages generally indicate the following:
Stage 0: Abnormal cells, such as ductal carcinoma in situ, remain confined to their original location and have not invaded surrounding breast tissue.
Stage I: Cancer is invasive but generally limited in extent, with a small tumor and no or limited nearby lymph node involvement.
Stage II: The tumor may be larger or involve a limited number of nearby lymph nodes, depending on the specific findings.
Stage III: Cancer is more extensive locally or regionally and may involve multiple nearby lymph nodes or surrounding structures.
Stage IV: Cancer has spread to distant organs or tissues, such as the bones, liver, lungs, or brain.
These descriptions are simplified because the exact stage depends on specific TNM measurements and other clinical factors. Tumor grade, estrogen and progesterone receptors, and HER2 status can also affect the assigned prognostic stage. Stage IV disease is also called metastatic breast cancer.
Breast cancer diagnosis typically begins with a medical history and clinical breast examination. If a suspicious lump, imaging abnormality, or other concerning change is identified, additional investigations may be recommended. No single test provides every piece of information required for diagnosis and staging.
Common diagnostic methods include:
Mammography: Uses low-dose X-rays to identify suspicious masses, calcifications, and other breast tissue changes.
Breast ultrasound: Uses sound waves to examine abnormalities and help distinguish fluid-filled cysts from solid masses.
Breast MRI: Produces detailed images and may be recommended for selected patients to assess disease extent or investigate particular findings.
Biopsy: Removes a sample of breast tissue for laboratory examination. A core needle biopsy is commonly used to confirm whether cancer is present.
Lymph node assessment: Ultrasound and needle sampling may help evaluate suspicious lymph nodes. Surgical evaluation can provide additional information when appropriate.
CT, bone scans, or PET/CT: These tests may be used when symptoms, examination findings, or the suspected disease stage indicate a need to investigate possible distant spread. They are not necessary for every patient.
Receptor and biomarker testing: Laboratory analysis of tumor tissue determines estrogen receptor, progesterone receptor, and HER2 status. These findings help guide treatment selection.
Once the results are available, the healthcare team combines the findings to establish the most appropriate stage and discuss treatment options. The required tests vary according to the individual clinical situation, and not every patient needs every investigation.
Understanding breast cancer staging and diagnostic methods can make medical discussions more informative. Patients can ask their healthcare team how the biopsy results, imaging findings, lymph node assessment, and tumor biomarkers contribute to the diagnosis. Regular follow-up and individualized medical guidance remain important throughout evaluation and treatment.